<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://regulatorynews.com/bambusa-therapeutics-nasdaq-ipo</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T09:42:09-04:00</news:publication_date>
      <news:title>Bambusa Therapeutics Prices $168.9M Nasdaq IPO</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/monebo-kinetic-ecg-library-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T09:42:09-04:00</news:publication_date>
      <news:title>Monebo Clears FDA for Kinetic ECG Software Library</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/x9-dialysis-cannulation-breakthrough-device</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T09:42:09-04:00</news:publication_date>
      <news:title>X9 Wins Second FDA Nod for Dialysis Needle Guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/inovio-voceryq-rrp-accelerated-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T06:00:30-04:00</news:publication_date>
      <news:title>FDA Clears Inovio&apos;s Voceryq for Airway Papillomas</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mhra-casgevy-age-five-extension</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T06:00:30-04:00</news:publication_date>
      <news:title>MHRA Extends Casgevy Gene Therapy to Children Aged Five</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/sun-pharma-ilumya-psoriatic-arthritis-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T06:00:30-04:00</news:publication_date>
      <news:title>FDA Approves Ilumya for Psoriatic Arthritis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/aspen-neuroscience-ipo-financing</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T11:06:58-04:00</news:publication_date>
      <news:title>Aspen Neuroscience Prices $140.6M Nasdaq IPO</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/deep-reasoning-ai-neurodr-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T11:06:58-04:00</news:publication_date>
      <news:title>Deep Reasoning AI Secures FDA Clearance for NeuroDR</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/roche-cobas-smart-e-ce-mark</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T11:06:58-04:00</news:publication_date>
      <news:title>Roche Wins CE Mark for cobas smart e Immunoanalyser</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/icotyde-icotrokinra-mhra-approval-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T10:45:52-04:00</news:publication_date>
      <news:title>UK Clears Oral Psoriasis Pill Already Used in US</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-estar-mandatory-ide-applications</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T05:55:52-04:00</news:publication_date>
      <news:title>FDA Drafts a Mandatory eSTAR Path for Device Trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-revises-drug-delivery-device-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T05:55:52-04:00</news:publication_date>
      <news:title>FDA Revises Its Drug-Delivery Device Test Guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/hhs-peptide-compounding-enforcement-discretion</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T05:55:52-04:00</news:publication_date>
      <news:title>HHS Clears Compounding of Six Unapproved Peptides</news:title>
    </news:news>
  </url>
</urlset>
